ARTEMIS: Stop Progression to Diabetes to Avoid CV Events ARTEMIS: Stop Progression to Diabetes to Avoid CV Events
ARTEMIS findings suggest efforts should be made to prevent progression to type 2 diabetes for patients with treated coronary artery disease and prediabetes.Medscape Medical News
The D2d trial showed that vitamin D supplementation does not prevent type 2 diabetes in those at risk. Drs Pittas and Shubrook discuss what else we can learn from this trial.Medscape Diabetes &Endocrinology
ConclusionExperimental validation of network analysis revealed anti-diabetic effects of the plant product SGD, manifested most notably by improved serum profiles and diminished insulin resistance. These experimental results may have clinical implications.Graphical abstract
In cardiovascular outcomes trials for type 2 diabetes drugs, data weren't significant for benefit among the small number of black and African American participants.Medscape Medical News
New Jersey’s largest health insurer has partnered with a biopharma vendor to optimize drug treatment using medical and pharmacy claims data. Horizon Healthcare Services will work with vendor Aetion to support case management strategies and develop value-based agreements with pharmas targeting specific patient populations. Aetion is in the business of providing payers and biopharma companies […]
TYPE 2 diabetes is a common condition caused by the body ’s inability to produce enough insulin to regulate blood sugar levels. It is strongly linked to being overweight and poor dietary decisions. Sticking to a low-carb meal plan can help to mitigate the risks associated with the life-long condition.
(Natural News) The number of people diagnosed with type 2 diabetes each year continues to increase. There can be little doubt that the standard American diet – high in junk food and sugary sodas, and low in healthier, nutritionally dense foods – has played a significant part in this increase, as has our sedentary lifestyle...
ConclusionsThus, galectin-3 might be a useful prognostic marker in the population with prediabetes and diabetes. Moreover, it can be a marker showing the condition of developing complications in diabetic patients.
ConclusionWe present a comprehensive mRNA expression profile of chromogranin A positive enteroendocrine cells following RYGB in rats. The data provides a region-specific characterization of all regulated preprohormone encoding genes in the rat GI tract including 16 not hitherto known. The comprehensive catalogue of preprohormone expression changes may support our understanding of hormone mediated effects of RYGB on diabetes remission and body weight reduction.Graphical abstract
In conclusions, dairy may be part of a healthy diet; however, additional studies exploring confounding factors are needed to ascertain the potential detrimental effects. PMID: 31199182 [PubMed - as supplied by publisher]
ConclusionsOur results indicate an impairment in autophagic flux in PBMCs from people with prediabetes when compared with control subjects in response to both exercise and RAPA treatment. Future methods of autophagic upregulation should be investigated to spare malfunctions in autophagy in people with prediabetes.RésuméObjectifsRécemment, il a été montré qu'un dysfonctionnement de la voie autophagique a été impliqué dans une altération du métabolisme du glucose et une progression d'un prédiabète en diabète de type 2. Les objec...